Abstract
Pembrolizumab leads to a durable response in ultra-hypermutated, high-grade, glioma.
MeSH terms
-
Brain Neoplasms* / drug therapy
-
Brain Neoplasms* / genetics
-
Genotype
-
Glioma* / drug therapy
-
Glioma* / genetics
-
Humans
-
Isocitrate Dehydrogenase / genetics
-
Mutation